Providence Medical Research Center, University of Washington School of Medicine, Spokane, 99210-1495, USA.
Clin J Am Soc Nephrol. 2012 Mar;7(3):409-16. doi: 10.2215/CJN.05070511. Epub 2012 Jan 19.
Rates of hospitalization are known to be high in patients with kidney disease. However, ongoing risks of subsequent hospitalization and mortality are uncertain. The primary objective was to evaluate patients with kidney disease for long-term risks of subsequent hospitalization, including admissions resulting in death.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Patients hospitalized in Washington State between April of 2006 and December of 2008 who survived to discharge (n=676,343) were classified by International Classification of Disease codes into CKD (n=27,870), dialysis (n=6131), kidney transplant (n=1100), and reference (n=641,242) cohorts. Cox proportional hazard models controlling for age, sex, payer, comorbidity, previous hospitalization, primary diagnosis category, and length of stay were conducted for time to event analyses.
Compared with the reference cohort, risks for subsequent hospitalization were increased in the CKD (hazard ratio=1.20, 99% confidence interval=1.18-1.23, P<0.001), dialysis (hazard ratio=1.76, 99% confidence interval=1.69-1.83, P<0.001), and kidney transplant (hazard ratio=1.85, 99% confidence interval=1.68-2.03, P<0.001) cohorts, with a mean follow-up time of 29 months. Similarly, risks for fatal hospitalization were increased for patients in the CKD (hazard ratio=1.41, 99% confidence interval=1.34-1.49, P<0.001), dialysis (hazard ratio=3.04, 99% confidence interval=2.78-3.31, P<0.001), and kidney transplant (hazard ratio=2.25, 99% confidence interval=1.67-3.03, P<0.001) cohorts. Risks for hospitalization and fatal hospitalization increased in a graded manner by CKD stage.
Risks of subsequent hospitalization, including admission resulting in death, among patients with kidney disease were substantially increased in a large statewide population. Patients with kidney disease should be a focus of efforts to reduce hospitalizations and mortality.
患有肾脏疾病的患者住院率很高。然而,后续住院和死亡的持续风险尚不确定。主要目的是评估患有肾脏疾病的患者的长期后续住院风险,包括导致死亡的住院。
设计、设置、参与者和测量:2006 年 4 月至 2008 年 12 月期间在华盛顿州住院且存活至出院的患者(n=676343)根据国际疾病分类代码分为慢性肾脏病(CKD)(n=27870)、透析(n=6131)、肾移植(n=1100)和参考(n=641242)队列。进行 Cox 比例风险模型分析,以控制年龄、性别、支付人、合并症、既往住院、主要诊断类别和住院时间,对事件时间进行分析。
与参考队列相比,CKD(危险比=1.20,99%置信区间=1.18-1.23,P<0.001)、透析(危险比=1.76,99%置信区间=1.69-1.83,P<0.001)和肾移植(危险比=1.85,99%置信区间=1.68-2.03,P<0.001)队列的后续住院风险增加,平均随访时间为 29 个月。同样,CKD(危险比=1.41,99%置信区间=1.34-1.49,P<0.001)、透析(危险比=3.04,99%置信区间=2.78-3.31,P<0.001)和肾移植(危险比=2.25,99%置信区间=1.67-3.03,P<0.001)队列中致命住院的风险增加。
在一个大型全州范围内的人群中,患有肾脏疾病的患者的后续住院风险,包括导致死亡的住院,显著增加。患有肾脏疾病的患者应成为降低住院率和死亡率的重点关注对象。